Loading…
Lobbying Spend
—
Filings
7
Firms Hired
1
Active Period
2017–2018
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
2018 · third_quarter · Firm: LESTER HEALTH LAW PLLC
hospital inpatient and outpatient prospective payment system; HR 4215 The Protect Access to Cellular Transplants Act
Client expense: — · Firm income: —
Matched citations: HR 4215
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
2018 · second_quarter · Firm: LESTER HEALTH LAW PLLC
hospital inpatient and outpatient prospective payment system; HR 4215 The Protect Access to Cellular Transplants Act
Client expense: — · Firm income: —
Matched citations: HR 4215
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
2018 · first_quarter · Firm: LESTER HEALTH LAW PLLC
hospital inpatient and outpatient prospective payment system; HR 4215 The Protect Access to Cellular Transplants Act
Client expense: — · Firm income: —
Matched citations: HR 4215
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
2017 · fourth_quarter · Firm: LESTER HEALTH LAW PLLC
hospital inpatient and outpatient prospective payment system; HR 4215 The Protect Access to Cellular Transplants Act
Client expense: — · Firm income: —
Matched citations: HR 4215
Source: Senate LDA